Viewing data from:

ENTACAPONE

ANDA

ENTACAPONE | A203437 | AUROBINDO PHARMA LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: COMTAN(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$0.3458

per ea

Lowest NADAC/Unit

$0.3458

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00904682207ENTACAPONE 200 MG TABLET	$0.3458	EA	Generic	—	2026-06-17
50268029515ENTACAPONE 200 MG TABLET	$0.3458	EA	Generic	—	2026-06-17
65862065401ENTACAPONE 200 MG TABLET	$0.3458	EA	Generic	—	2026-06-17
60687018821ENTACAPONE 200 MG TABLET	$0.3458	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain13 active DMFs7 inactive

12 active API suppliers hold Drug Master Files for this ingredient.

FERMION OYENTACAPONE

DMF 124441997

SUVEN PHARMACEUTICALS LTDENTACAPONE

DMF 190922006

WOCKHARDT LTDENTACAPONE USP

DMF 193852006

SUN PHARMACEUTICAL INDUSTRIES LTDENTACAPONE

DMF 203262007

NEULAND LABORATORIES LTDENTACAPONE USP (FORM-A)

DMF 215262008

COHANCE LIFESCIENCES LTDENTACAPONE USP

DMF 239372010

APITORIA PHARMA PRIVATE LTDENTACAPONE USP (NON-STERILE DRUG SUBSTANCE)

DMF 241882010

JUBILANT BIOSYS LTDENTACAPONE

DMF 243612010

MACLEODS PHARMACEUTICALS LTDENTACAPONE

DMF 254102011

HETERO LABS LTDENTACAPONE

DMF 265012012

HEC PHARM CO LTDENTACAPONE NON-STERILE BULK DRUG SUBSTANCE

DMF 271092013

PIRAMAL PHARMA LTDENTACAPONE

DMF 290102015

SUVEN PHARMACEUTICALS LTDENTACAPONE USP

DMF 333302018

USV LTDInactiveENTACAPONE

DMF 221332008

DIPHARMA FRANCIS SRLInactiveENTACAPONE

DMF 225382009

ARCH PHARMALABS LTDInactiveENTACAPONE

DMF 227142009

RANBAXY LABORATORIES LTDInactiveENTACAPONE

DMF 234122009

STANDARD CHEM AND PHARM CO LTDInactiveENTACAPONE

DMF 238042010

ERREGIERRE SPAInactiveENTACAPONE

DMF 239332010

FIS FABBRICA ITALIANA SINTETICI SPAInactiveENTACAPONE

DMF 239842010

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 200MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jun 19, 2015

No patent or exclusivity listings for this strength.